Overview
Pailong Biotech develops innovative drugs using AI and emerging biotechnology, aiming to provide effective, safe and clinically practical treatments for difficult diseases. Works with advanced global automated AI drug discovery and other emerging technology platforms on clinically important therapeutic targets, accelerating drug development and optimization. Its initial focus is small-molecule oncology drugs. Targets tumor cell cycles through next-generation CDK inhibitors and uses synthetic lethality to discover anticancer drugs.
Connected profiles
Explore
More Health management products
Sources · 0Sources & provenance
English text is maintained separately from the original record. Consult the original source before citing a fact.
No source links are available for this profile.
Original source text
Names may use phonetic renderings when no English name is supplied. The original wording is retained below.
湃隆生物是一家基于人工智能技术的创新药物研发商，致力于以人工智能和新型生物技术为主导的创新药物开发，利用人工智能技术开发在研新药，旨在为难治性疾病提供有效、安全且符合临床实际的药物。湃隆生物与全球先进的自动化人工智能药物发现平台和其他新兴技术平台合作，针对重大临床意义的治疗靶点，旨在通过新技术加速新药研发，提供药物优化。湃隆生物以肿瘤小分子新药研发作为初期研发重点。湃隆生物正在通过一系列新一代CDK抑制剂来瞄准肿瘤细胞周期，并利用合成致死作用来发现抗肿瘤药物。